{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:54:38Z","timestamp":1777672478114,"version":"3.51.4"},"reference-count":10,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine High Impact Case Reports"],"published-print":{"date-parts":[[2014,7,1]]},"abstract":"<jats:p>The health risks and side effects of fluoroquinolone use include the risk of tendon rupture and myasthenia gravis exacerbation, and on August 15, 2013, the Food and Drug Administration updated its warning to include the risk of permanent peripheral neuropathy. We present a case of fluoroquinolone-induced peripheral neuropathy in a patient treated for clinically diagnosed urinary tract infection with ciprofloxacin antibiotic.<\/jats:p>","DOI":"10.1177\/2324709614545225","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T20:16:40Z","timestamp":1406578600000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Permanent Peripheral Neuropathy"],"prefix":"10.1177","volume":"2","author":[{"given":"Jacquelyn K.","family":"Francis","sequence":"first","affiliation":[{"name":"Albany Medical College, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Higgins","sequence":"additional","affiliation":[{"name":"Albany Medical College, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,9,22]]},"reference":[{"key":"bibr1-2324709614545225","unstructured":"US Food and Drug Administration. FDA drug safety communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm365050.htm. Accessed August 15, 2013."},{"key":"bibr2-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_5.S1194"},{"key":"bibr3-2324709614545225","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958002-00006"},{"key":"bibr4-2324709614545225","unstructured":"Hooper DC, Wolfson JS. Mechanisms of Quinolone Action and Bacterial Killing. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993:53-57."},{"key":"bibr5-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1007\/BF00229745"},{"key":"bibr6-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Z429"},{"key":"bibr7-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.4.831"},{"key":"bibr8-2324709614545225","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.16.5.458"},{"key":"bibr9-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1155\/2002\/864789"},{"key":"bibr10-2324709614545225","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.09.015"}],"container-title":["Journal of Investigative Medicine High Impact Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2324709614545225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2324709614545225","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2324709614545225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:05:05Z","timestamp":1777449905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2324709614545225"}},"subtitle":["A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration"],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7,1]]}},"alternative-id":["10.1177\/2324709614545225"],"URL":"https:\/\/doi.org\/10.1177\/2324709614545225","relation":{},"ISSN":["2324-7096","2324-7096"],"issn-type":[{"value":"2324-7096","type":"print"},{"value":"2324-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]},"article-number":"2324709614545225"}}